Equities

Alembic Ltd

ALEMBICLTD:NSI

Alembic Ltd

Actions
Real EstateReal Estate Investment and Services
  • Price (INR)120.23
  • Today's Change4.45 / 3.84%
  • Shares traded4.28m
  • 1 Year change+64.59%
  • Beta1.4406
Data delayed at least 15 minutes, as of Jul 05 2024 11:27 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

  • Revenue in INR (TTM)1.57bn
  • Net income in INR2.69bn
  • Incorporated1907
  • Employees271.00
More ▼

Institutional shareholders

0.67%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 06 Jun 20241.48m0.58%
Dimensional Fund Advisors Ltd.as of 30 Apr 2024106.23k0.04%
American Century Investment Management, Inc.as of 06 Jun 2024104.54k0.04%
DFA Australia Ltd.as of 31 May 202422.27k0.01%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.